Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: A phase II study

International Journal of Cancer

Volumn 131, Issue 5, 2012, Pages 1228-1234

  Yano, Tomonori ^a   Muto, Manabu ^b   Minashi, Keiko ^a   Iwasaki, Junko ^a   Kojima, Takashi ^a   Fuse, Nozomu ^a   Doi, Toshihiko ^a   Kaneko, Kazuhiro ^a   Ohtsu, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Esophageal squamous cell carcinoma; Photodynamic therapy; Salvage treatment

Indexed keywords

CISPLATIN; FLUOROURACIL; PHOTOFRIN;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYE LASER; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXCIMER LASER; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SALVAGE THERAPY; SORE THROAT; THORAX PAIN; TREATMENT FAILURE; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DIHEMATOPORPHYRIN ETHER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LASERS, DYE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84863203881     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27320     Document Type: Article

References (21)

1. Swisher SG, Wynn P, Putnum JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002;123:173-83.
2. Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M, Doki Y. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 2009;100:442-6.
3. Tachimori Y, Kanamori N, Uemura N, Hosokawa N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2009;137:49-54.
4. Chao YK, Chan SC, Chang HK, Liu YH, Wu YC, Hsieh MJ, Tseng CK, Liu HP. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur J Surg Oncol 2009;35:289-294.
5. Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, Ohtsu A, Ogino T. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of thoracic esophagus. Radiother Oncol 2009;92:266-9.
6. Hattori S, Muto M, Ohtsu A, Boku N, Manabe T, Doi T, Ishikura S, Yoshida S. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2003;58:65-70. (Pubitemid 38208749)
7. Yano T, Muto M, Hattori S, Minashi K, Onozawa M, Nihei K, Ishikura S, Ohtsu A, Yoshida S. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 2008;40:717-21.
8. Yano T, Muto M, Minashi K, Ohtsu A, Yoshida S. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2005;62:31-6. (Pubitemid 40922437)
9. Savary JF, Grossjean P, Monnier P, Fontolliet C, Waqnieres G, Braichotte D, van den Berqh H. Photodynamic therapy of early squamous cell carcinoma of esophagus: a review of 31 cases. Endoscopy 1998;30:258-65. (Pubitemid 28223111)
10. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995;108:337-44.
11. Litle VR, Luketich JD, Christie NA, Buenaventura PO, Alvelo-Rivera M, McCaughan JS, Nguyen NT, Fernando HC. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg 2003;76:1687-93. (Pubitemid 37378339)
12. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events (CTCAE), Version 3.0, DCTD, NCI, NIH, DHHS. March 31, 2003, Available at: http://ctep.cancer.gov/forms/ CTCAEv3.pdf. Accessed on August 9, 2006.
13. Sobin LH, Wittekind C, eds. TNM classification of malignant tumors, 5th edn. New York: Wiley-Liss, 1997.
14. Yano T, Muto M, Minashi K, Onozawa M, Nihei K, Ishikura S, Kaneko K, Ohtsu A. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 2011;43:657-63.
15. Nakamura T, Fukui H, Shirakawa K, Fujii Y, Fujimori T, Terano A. Photodynamic therapy of superficial esophageal cancer with a transparent hood. Gastrointest Endosc 2004;60:120-4. (Pubitemid 38833717)
16. Borghesi S, Hawkins MA, Tait D. Oesophagectomy after definitive chemoradiation in patients with locally advanced esophageal cancer. Clin Oncol 2008;20:221-6.
17. Conroy T, Etienne PL, Adenis A, Wagener DJ, Paillot B, François E, Bedenne L, Jacob JH, Seitz JF, Bleiberg H, Van Pottelsberghe C, Van Glabbeke M, et al. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. J Clin Oncol 1996;14:164-70. (Pubitemid 26020009)
18. Lordick F, von Schilling C, Bernhard H, Hennig H, Bredenkamp R, Peschel C. Phase II study of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer. Br J Cancer 2003;89:630-3. (Pubitemid 37076164)
19. Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, Fujita H, Takiyama W, Ohtsu T. A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 2004;15:955-9. (Pubitemid 39004353)
20. Park BB, Im YH, Hwang IG, Lee SC, Ahn JS, Ahn MJ, Lim HY, Kang WK, Par k K. Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma. Invest News Drugs 2008;26:387-92.
21. Tu CH, Muto M, Horimatsu T, Taku K, Yano T, Minashi K, Onozawa M, Nihei K, Ishikura S, Ohtsu A, Yoshida S. Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Dis Esophagus 2010;24:274-8.